MPO and Stroke: Notably, the administration of ABAH, a specific and irreversible inhibitor of MPO, exhibited remarkable outcomes in mitigating the inflammatory response, reducing MPO activity, enhancing neurological outcomes, and improving the mortality rate in the aged group after stroke.